Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities
Net earnings (loss)	$ (158,764)	$ (259,458)	$ 234,759
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation	271,601	267,562	207,132
Amortization	288,160	414,125	79,647
Share-based compensation expense	126,049	148,872	73,214
Non-cash restructuring charges	16,557	119,456	0
Amortization of discount on convertible debt and debt issuance costs	17,652	19,850	18,807
Losses on disposals of property, plant & equipment	758	2,440	617
Unrealized losses (gains) on foreign currency remeasurements and transactions	(10,556)	(3,549)	1,167
Loss (earnings) from equity investments	51	66	(2,190)
Deferred income taxes	(112,096)	(206,822)	(8,154)
Loss on debt extinguishment	1,978	6,855	0
Increase (decrease) in cash from changes in (net of effects of acquisitions):
Accounts receivable	60,581	68,315	(55,193)
Inventories	(23,196)	174,136	(230,882)
Accounts payable	205,044	(83,330)	97,053
Contract liabilities	(72,818)	(18,957)	26,614
Income taxes	12,251	28,651	17,961
Accrued compensation and benefits	36,894	(60,595)	(9,382)
Other operating net assets (liabilities)	(114,415)	16,408	(37,838)
Net cash provided by operating activities	545,731	634,025	413,332
Cash Flows from Investing Activities
Additions to property, plant & equipment	(346,816)	(436,060)	(314,332)
Purchases of businesses, net of cash acquired	0	(5,488,556)	0
Other investing activities	(3,897)	(4,010)	(5,750)
Net cash used in investing activities	(350,713)	(5,928,626)	(320,082)
Cash Flows from Financing Activities
Sale of shares to noncontrolling interests	1,000,000	0	0
Proceeds from issuance of Series B preferred shares	0	1,400,000	0
Proceeds from borrowings of revolving credit facilities	18,966	65,000	0
Proceeds from issuance of Senior Notes	0	0	990,000
Payments on existing debt	(228,802)	(1,265,175)	(62,050)
Payments on borrowings under Revolving Credit Facilities	(19,027)	(65,000)	0
Payments on convertible notes	0	(3,561)	0
Payment of Finisar Notes	0	0	(14,888)
Debt issuance costs	0	(126,516)	(10,197)
Equity issuance costs	(31,840)	(42,000)	0
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan	42,297	24,167	17,858
Payments in satisfaction of employees’ minimum tax obligations	(22,315)	(54,172)	(21,249)
Cash dividends paid	0	(27,600)	(34,508)
Other financing activities	(1,007)	(1,124)	(2,013)
Net cash provided by financing activities	758,272	3,554,019	862,953
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(1,170)	(4,223)	34,276
Net increase in cash and cash equivalents, and restricted cash	952,120	(1,744,805)	990,479
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	837,566	2,582,371	1,591,892
Cash, Cash Equivalents, and Restricted Cash at End of Period	1,789,686	837,566	2,582,371
Supplemental Information
Cash paid for interest	312,879	282,835	57,314
Cash paid for income taxes	97,295	89,567	50,000
Non-Cash Investing and Financing Activities:
Additions to property, plant & equipment included in accounts payable	63,286	36,777	84,890
Conversion of Series A preferred stock to common stock	445,319	0	0
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Restricted cash	864,000	16,000
Cash and cash equivalents	926,033	821,310	2,582,371
Restricted cash, current	174,008	12,023	0
Restricted cash, non-current	689,645	4,233	0
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	1,789,686	837,566	2,582,371
Term B Facility
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility	0	2,800,000	0
Term A Facility
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility	$ 0	$ 850,000	$ 0